Table 1.
Cohort | Case, number (frequency) | Control, number (frequency) | P value | OR (95% CI) |
---|---|---|---|---|
New Zealand | ||||
Minor allele | 501 (0.339) | 408 (0.369) | 0.11 | 0.88 (0.75-1.03) |
Genotype 1,1 | 326 (0.38) | 210 (0.38) | - | 1 |
1,2 | 327 (0.44) | 278 (0.50) | 0.021 | 0.76 (0.60-0.96) |
2,2 | 87 (0.12) | 65 (0.12) | 0.43 | 0.86 (0.60-1.24) |
HWE | 0.72 | 0.061 | ||
Dominant | 0.028 | |||
Additive | 0.10 | |||
Recessive | 0.99 | |||
Oxford, UK | ||||
Minor allele | 506 (0.355) | 329 (0.319) | 0.068 | 1.17 (0.99-1.39) |
Genotype 1,1 | 300 (0.42) | 235 (0.46) | - | 1 |
1,2 | 319 (0.45) | 231 (0.45) | 0.52 | 1.08 (0.85-1.38) |
2,2 | 93 (0.13) | 49 (0.10) | 0.044 | 1.49 (1.01-2.19) |
HWE | 0.60 | 0.47 | ||
Dominant | 0.22 | |||
Additive | 0.069 | |||
Recessive | 0.055 | |||
WTCCC | ||||
Minor allele | 1,141 (0.344) | 1,928 (0.365) | 0.044 | 0.91 (0.83-1.00) |
Genotype 1,1 | 708 (0.43) | 1,044 (0.40) | - | 1 |
1,2 | 761 (0.46) | 1,262 (0.48) | 0.079 | 0.89 (0.78-1.01) |
2,2 | 190 (0.11) | 333 (0.13) | 0.094 | 0.84 (0.69-1.03) |
HWE | 0.50 | 0.11 | ||
Dominant | 0.043 | |||
Additive | 0.041 | |||
Recessive | 0.26 | |||
Jacq et al. [20] | ||||
Minor allele | 292 (0.352) | 343 (0.413) | 0.01 | 0.77 (0.63-0.94) |
Genotype 1,1 | 166 (0.40) | 148 (0.36) | - | 1 |
1,2 | 206 (0.50) | 191 (0.46) | 0.80 | 0.96 (0.71-1.29) |
2,2 | 43 (0.10) | 76 (0.18) | 0.002 | 0.50 (0.33-0.78) |
HWE | 0.0718 | 0.30 | ||
Dominant | 0.20 | |||
Additive | 0.0096 | |||
Recessive | 0.0011 | |||
Combined | ||||
Minor allele | 2,440 (0.346) | 3,008 (0.365) | 0.014 | 0.92 (0.86-0.98) |
Genotype 1,1 | 1,500 (0.43) | 1,637 (0.40) | - | 1 |
1,2 | 1,614 (0.46) | 1,966 (0.48) | 0.028 | 0.90 (0.81-0.99) |
2,2 | 413 (0.12) | 523 (0.13) | 0.046 | 0.86 (0.74-1.00) |
HWE | 0.51 | 0.083 | ||
Dominant | 0.011 | |||
Additive | 0.013 | |||
Recessive | 0.20 |
CI, confidence interval; HWE, Hardy-Weinberg equilibrium P value; OR, odds ratio; WTCCC, Wellcome Trust Case Control Consortium.